Brief: Tela Bio Announces Sale Of Distribution Rights For Wound Care Product To Mimedx
March 20 (Reuters) - TELA Bio Inc TELA.O :
* TELA BIO ANNOUNCES SALE OF DISTRIBUTION RIGHTS FOR WOUND
CARE
PRODUCT TO MIMEDX
* TELA BIO INC - AS CONSIDERATION FOR SALE, MIMEDX WILL MAKE
AN
INITIAL $5.0 MILLION PAYMENT
* TELA BIO- MIMEDX WILL MAKE FUTURE PAYMENTS BETWEEN
MINIMUM OF
$3.0 MILLION AND $7.0 MILLION BASED ON NET SALES OF NIVIS OVER
NEXT TWO YEARS
Source text for Eikon: ID:nGNXbYWJ87
Further company coverage: TELA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TELA Bio
See all newsBrief: Tela Bio - Receives FDA 510(K) Clearance For Liora Monofilament Scaffold For Soft Tissue Reinforcement
Tela Bio Inc Reports Results For The Quarter Ended June 30: Earnings Summary
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook
Brief: TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million
Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview